Provider review
AlyveRx review
The same tirzepatide carries two different prices on one page load.
One part of the homepage prices compounded tirzepatide at one figure; another part of the same render prices it lower. Reproduced on a second fetch, so it is not a caching artifact — the starting point you budget from depends on where you look.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
AlyveRx
Tirz $283–$329/mo (two prices) · sema from $183/mo
- Vs median
- $14/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
AlyveRx has one feature a low-dose reader should care about: it sells injection-free sublingual drops for both molecules, each with its own published rate, rather than treating the needle-free route as a special request. That is a real option for someone taking a small amount who does not want to inject weekly. It also lets you route the prescription to a pharmacy of your own choosing instead of forcing its network, which is unusual. Against that sits a pricing page that contradicts itself. The same compounded tirzepatide appears at two different figures in a single render, and both are floors — every GLP-1 rate here is a "starting at" with no higher rung published anywhere. When a provider cannot state its own entry price consistently, treat every figure on the page as provisional and get a quote in writing before you commit.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a needle-free route priced openly rather than quoted on request.
- You want to send the prescription to your own pharmacy rather than an in-house network.
Look elsewhere if
- You are budgeting from the advertised entry price. There are two of them for the same product.
- You are pricing a dose increase. Every figure is a floor with nothing published above it.
- You want the compounding pharmacy named.
What it actually costs
Price as published
Compounded tirzepatide is advertised at BOTH $329/month and "Starting at $283/mo" on the same homepage, in the same render · compounded semaglutide starting at $183/month · tirzepatide sublingual drops starting at $249/month · semaglutide sublingual drops starting at $203/month · compounded NAD+ starting at $129/month · brand Ozempic starting at $1,395/month · every GLP-1 figure is a "starting at", so no higher-dose rung is published
- Vs median
- $14/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
36 of the 373 programs we track price a small dose this way. Injectable and sublingual forms are priced separately for both molecules, which genuinely helps someone at a low dose who would rather not inject — the needle-free route has its own rate instead of being quoted on request. Every one of those rates is a floor, though, and the injectable tirzepatide floor is itself published at two different figures in a single render, so the starting point a patient budgets from depends on which part of the page they read.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Sells injection-free sublingual drops for both molecules at their own published rates, which is a real option for a low-dose patient who does not want to inject
- Lets a patient request that the prescription be sent to a pharmacy of their choice rather than forcing the in-house network
- Puts compounded and brand Ozempic in the same catalog with prices attached to both, so the gap is visible
- Prices compounded NAD+ separately rather than bundling it invisibly into a weight-loss plan
Pharmacy, labs and oversight
AlyveRx dispenses through a Not named — an in-network "Pharmacy Network" of licensed pharmacies and compounding facilities facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What AlyveRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
AlyveRx sells compounded semaglutide and tirzepatide in both injectable and injection-free sublingual-drop forms, alongside compounded NAD+ and brand Ozempic, framing the catalog around weight loss and healthy aging. Splitting each molecule into an injectable and a drop, each separately priced, is genuinely useful to someone who wants to avoid needles at a low dose. The pricing itself is where it falls down: the same compounded tirzepatide carries two different published figures on one page load, and every GLP-1 rate is a "starting at" with no second rung published against it. Its terms describe fulfillment through an unnamed network of licensed pharmacies and compounding facilities, though a patient may request a pharmacy of their own choosing.
The honest cons
TWO PRICES FOR ONE PRODUCT. Compounded tirzepatide is published at $329/month in one place on the homepage and "Starting at $283/mo" in another, in the same render — reproduced on a second fetch, so it is not a caching artifact
- Every GLP-1 figure is a "starting at" floor with no higher-dose rung published, so a dose increase has an unknown price
- No pharmacy is named — its terms describe only "licensed pharmacies or compounding facilities within our network"
- No LegitScript seal is displayed
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
AlyveRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#164 of 373
Ordered with the companies that pay us first, and AlyveRx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Sublingual troches and drops
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Elara MD
$249/mo at 0.2 mg/wk semaglutide
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Compounded, 503A pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Elara MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.